Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual Meeting
Posted on: Wednesday, 22 April 2009, 23:01 CDT
Computer-Guided Interactive HoLEP Simulator
The abundance of clinical evidence suggests that HoLEP provides superior outcomes and long term durability in treating Benign Prostatic Hyperplasia (BPH) of all gland sizes(2). There has been increasing interest from physicians to learn HoLEP. Dr.
There is a body of clinical evidence that shows that HoLEP provides superior treatment outcomes and is durable long-term. The training simulator is an effective tool that allows more physicians to be trained on the HoLEP procedure. "The clinical data supporting the superiority of the HoLEP procedure is significant," says Mr.
HoLEP is performed using Lumenis' VersaPulse(R) PowerSuite(TM) laser with the VersaCut(TM) Morcellator system. Mr.
PolyScope Disposable Ureteroscope(1)
Lumenis will also display the PolyScope Disposable Ureteroscope at the AUA. Dr.
The PolyScope is an evolutionary step in flexible scope design incorporating a truly disposable ureteroscope with a reusable 10,000 pixel fiber optic. This unique concept solves many of the drawbacks encountered with the use of standard flexible scopes. Because the PolyScope is disposable, it eliminates costly repairs, possible scope contamination and sterilization issues that can be associated with traditional scopes.
"The total cost (purchase price, maintenance and repair) of using reusable flexible ureteroscopes is high and they must be repaired on a regular basis," said Dr.
"The PolyScope is not just an important product for the flexible endoscopy market, but also for Lumenis," stated Mr.
Expert Physicians to Present in the Lumenis Booth at the AUA Meeting
Experienced thought-leading physicians will be at the Lumenis booth to present HoLAP and HoLEP and their own experiences using PowerSuite and PolyScope, including Drs.
About VersaPulse PowerSuite
The PowerSuite laser system, the first holmium laser cleared by the FDA for treatment of Benign Prostatic Hyperplasia (BPH), is also effective for surgical removal of stones, tumors and strictures. It offers a comprehensive solution for physicians and their patients. For more information about VersaPulse PowerSuite laser, log onto: www.surgical.lumenis.com.
About Lumenis
Lumenis is Israel's largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems. For more information about Lumenis and its products, log onto www.lumenis.com.
For further information contact:
Michelle Maydan Director of Corporate Communications 1-866-569-0597 +972-4-959-9004 e-mail: mmaydan@lumenis.comLumenis(R), its logo, VersaPulse(R) PowerSuite(TM) and VersaCut(TM) Morcellator are trademarks or registered trademarks of the Lumenis Group of Companies.
(1) PolyScope is not released for sale in the
(2) 2007,
SOURCE Lumenis Ltd.
Source: PR Newswire
Related Articles
- New Pre-Clinical Data on OmniGuide's BeamPath NEURO(TM) Demonstrates Precise Cutting in Brain Tissue
- Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papules (PPP) Procedure
- American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy As Treatment Option for Prostate Cancer Patients
- One in Ten Retail Clinic Users Replacing Their Primary Care Physician With Retail Clinic for Treatment of Common Ailments
- Dermacare Adds 4 New Clinics in Third Quarter of 2006
- Dermacare Awards Northwestern Franchises to Drs. Kenneth Egli and Sidney B. Smith
- Dermacare Forms Corporate Medical Board of Directors
- Dermacare Adds 7 New Clinics in Second Quarter of 2006
- GE Healthcare's Centricity Electronic Medical Record Receives Certification for Physician Offices and Clinics
- GE Healthcare Installs First Volume CT System Dedicated Exclusively for Pediatric Applications; LightSpeed VCT to Be Used in Clinical Research on Children With Heart Defects
User Comments (0)

RSS Feeds